Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2452223 | 0.85 | — | — | |
| SCHEMBL18108299 | 0.83 | — | — | |
| SCHEMBL18108075 | 0.79 | TSHR (0.36) | TSHRTDP1ALDH1A1 | |
| SCHEMBL18108048 | 0.79 | TSHR (0.36) | TSHRTDP1ALDH1A1 | |
| SCHEMBL56370 | 0.78 | TSHR (0.35) | TSHRTDP1ALDH1A1 | |
| SCHEMBL1224130 | 0.78 | TSHR (0.35) | TSHRTDP1ALDH1A1 | |
| SCHEMBL1225383 | 0.78 | TSHR (0.35) | TSHRTDP1ALDH1A1 | |
| SCHEMBL56265 | 0.78 | TSHR (0.35) | TSHRTDP1ALDH1A1 | |
| SCHEMBL56580 | 0.75 | TSHR (0.36) | TSHRTDP1ALDH1A1 | |
| SCHEMBL2453787 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1963340-B1 | METHOD FOR THE PRODUCTION OF (MERCAPTOORGANYL)ALKYL POLYETHER SILANES | EVONIK DEGUSSA GMBH (DE) | 2011-09-14 | — | — | EP | disclosed |
| US-7799938-B2 | Method for the production of (mercaptoorganyl)alkyl polyether silanes | EVONIK DEGUSSA GMBH (DE) | 2010-09-21 | — | — | US | disclosed |
| US-20080319128-A1 | Method for the production of (Mercaptoorgany)alkyl polyether silanes | EVONIK DEGUSSA GMBH (DE) | 2008-12-25 | — | — | US | disclosed |
| EP-1700861-B1 | Process for preparing organosilanes | DEGUSSA (DE) | 2007-08-15 | — | — | EP | disclosed |
| EP-1700861-A1 | Process for preparing organosilanes | Degussa GmbH (DE) | 2006-09-13 | — | — | EP | disclosed |
| EP-1529782-B1 | Process for preparing mercaptoorganyl alkoxy silanes | DEGUSSA (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-7019160-B2 | Process for the preparation of (mercaptoorganyl)alkoxysilanes | DEGUSSA AG (DE) | 2006-03-28 | — | — | US | disclosed |
| EP-1538152-B1 | Process for the preparation of (mercaptoorganyl)-alkoxysilanen | DEGUSSA (DE) | 2006-03-22 | — | — | EP | disclosed |
| US-6995280-B2 | Process for preparing (mercaptoorganyl)alkoxysilanes | DEGUSSA AG (DE) | 2006-02-07 | — | — | US | disclosed |
| US-20050124822-A1 | Process for the preparation of (mercaptoorganyl)alkoxysilanes | EVONIK OPERATIONS GMBH (DE) | 2005-06-09 | — | — | US | disclosed |
| US-20050124821-A1 | Process for preparing (mercaptoorganyl)alkoxysilanes | EVONIK OPERATIONS GMBH (DE) | 2005-06-09 | — | — | US | disclosed |
| EP-1529782-A1 | Process for preparing mercaptoorganyl alkoxy silanes | Degussa AG (DE) | 2005-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124821-A1 | Process for preparing (mercaptoorganyl)alkoxysilanes | ADH1C, ADH1A, MPST | TSHR 4084/4885TDP1 4712/4885ALDH1A1 670/4885 |
| US-20050124822-A1 | Process for the preparation of (mercaptoorganyl)alkoxysilanes | MPST, ADH1A, ADH1C | TSHR 3755/4885TDP1 4748/4885ALDH1A1 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.